| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.00M | - | |
| Other | 52.8K | $8.64M | - | |
| Other | 46.8K | $7.66M | - | |
| Other | 39.6K | $6.49M | -36,937 | |
| Other | 36.8K | $6.04M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2019 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 60,000 | $92.92 | $5,575,438.00 | -20.9% | |
| Jul 30, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 44,356 | $92.77 | $4,114,857.63 | -13.5% | |
| Jul 15, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 30,680 | $87.50 | $2,684,506.14 | -17.8% | |
| Jul 15, 2019 | Benevich Eric62 | Chief Commercial Officer | Sell | 5,835 | $87.44 | $510,201.31 | -28.1% | |
| Jul 11, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 7,220 | $87.63 | $632,716.64 | -2.5% | |
| Jun 18, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 2,100 | $87.82 | $184,416.54 | -1.5% | |
| Jun 13, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 17,268 | $82.62 | $1,426,627.81 | -5.7% | |
| Jun 3, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 3,435 | $85.51 | $293,718.61 | -2.4% | |
| May 31, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 19,297 | $85.02 | $1,640,580.77 | -12.0% | |
| May 24, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 17,486 | $80.03 | $1,399,434.31 | -11.0% |